Ikarian Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-216,989
| Closed | -$7.86M | – | 143 |
|
|
2025
Q1 | $7.86M | Buy |
216,989
+38,000
| +21% | +$1.38M | 0.97% | 10 |
|
|
2024
Q4 | $7.53M | Sell |
178,989
-11
| -0% | -$463 | 1.02% | 11 |
|
|
2024
Q3 | $9.94M | Buy |
+179,000
| New | +$9.94M | 1.39% | 8 |
|
|
2023
Q4 | – | Sell |
-174,945
| Closed | -$6.24M | – | 112 |
|
|
2023
Q3 | $6.24M | Buy |
174,945
+53,287
| +44% | +$1.9M | 0.75% | 13 |
|
|
2023
Q2 | $5.61M | Buy |
+121,658
| New | +$5.61M | 0.89% | 16 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 206 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 225 |
|
|
2020
Q3 | – | Sell |
-2,313
| Closed | -$181K | – | 143 |
|
|
2020
Q2 | $181K | Sell |
2,313
-11,939
| -84% | -$934K | 0.01% | 73 |
|
|
2020
Q1 | $633K | Sell |
14,252
-35,748
| -71% | -$1.59M | 0.05% | 57 |
|
|
2019
Q4 | $2.14M | Buy |
+50,000
| New | +$2.14M | 0.35% | 21 |
|